Biblio Discovery — Demo Discovery Service

29 hasil

Menampilkan 1–20 · 0,62 detik · RSS

Jurnal

Frontiers in Tuberculosis

ISSN 2813-7868 · Frontiers Media S.A. · 29 artikel di indeks

  1. Artikel Jurnal

    The “yeast-drop” treatment protocol in the Drosophila model for rapid and cost-effective TB drug testing

    Maria Vidal; Esther Fuentes; Nerea Escobar dkk.

    Frontiers in Tuberculosis, Vol. 4 · 2026 · Inggris · DOAJ

    BackgroundPulmonary tuberculosis (TB), caused by Mycobacterium tuberculosis, is the leading infectious disease globally. The lengthy treatment regimen and the potential side effects increase the probability of relapse and of developing drug resistance. These factors highlight the need for new…

  2. Artikel Jurnal

    Bidirectional pathogenesis between non-tuberculous mycobacteria and bronchiectasis: clinical insights, diagnostic challenges and future directions—Perspectives from South Asia

    Amresh Kumar Singh; Sneha Singh; Nandini Singh dkk.

    Frontiers in Tuberculosis, Vol. 3 · 2026 · Inggris · DOAJ

    Non-tuberculous mycobacteria (NTM) are environmental opportunistic pathogens causing chronic pulmonary disease. NTM pulmonary disease (NTM-PD) and bronchiectasis exhibit a bidirectional pathogenic relationship that is particularly under recognized in South Asian regions with high tuberculosis (TB)…

  3. Artikel Jurnal

    Evaluation of host-immune biomarker signatures as multiplex qPCR diagnostic assays: a pilot study toward meeting WHO target product profiles for TB diagnosis in India

    Harriet N. Garlant; Kalaiarasan Ellappan; Noyal Mariya Joseph dkk.

    Frontiers in Tuberculosis, Vol. 3 · 2026 · Inggris · DOAJ

    BackgroundTuberculosis (TB) remains the leading cause of death from a single infectious agent. Current diagnostic tools are limited, especially in low-resource settings. The World Health Organization's (WHO) Target Product Profiles (TPPs) call for rapid, non-sputum-based diagnostics with high…

  4. Artikel Jurnal

    An integrated psycho-social intervention to improve self-efficacy toward TB treatment uptake and infection prevention among patients and family caregivers: a multicentric implementation research study protocol

    Karikalan Nagaraj; Bella Devaleenal Daniel; Chandra Suresh dkk.

    Frontiers in Tuberculosis, Vol. 4 · 2026 · Inggris · DOAJ

    BackgroundThe individuals with tuberculosis (TB) experience a variety of barriers, needs, and challenges when receiving the treatment. Evidence on holistic patient-centered psychosocial interventions that promote self-efficacy and the ability to complete treatment-related tasks and goals is scarce…

  5. Artikel Jurnal

    Acceptability and feasibility of oral swabs for tuberculosis diagnosis in young children: a qualitative study from Uganda and Peru

    Francesca W. Basile; Rodrigo Calderón-Flores; Franziska Held dkk.

    Frontiers in Tuberculosis, Vol. 4 · 2026 · Inggris · DOAJ

    BackgroundTuberculosis (TB) remains a leading cause of morbidity and mortality in young children, particularly in settings with limited diagnostic capacity. Oral swabs represent a promising alternative specimen type due to their ease of collection, but evidence regarding their acceptability and…

  6. Artikel Jurnal

    Research overview—2025: integrating scientific progress to accelerate global tuberculosis elimination

    Patrick K. Moonan; Timothy H. Holtz

    Frontiers in Tuberculosis, Vol. 4 · 2026 · Inggris · DOAJ

    Major scientific advances across the tuberculosis research continuum emerged in 2025, offering new opportunities to accelerate progress toward global elimination. This review synthesizes developments in diagnosis, treatment, prevention, and post-disease care, highlighting innovations that broaden…

  7. Artikel Jurnal

    Identification of novel DNA gyrase B inhibitors in Mycobacterium species using integrated computational approaches

    Jagritee Yadav; Lalhmangaihzuali; Harish Shukla dkk.

    Frontiers in Tuberculosis, Vol. 4 · 2026 · Inggris · DOAJ

    IntroductionDrug-resistant Mycobacterium tuberculosis remains a major global health challenge, particularly due to the emergence of multidrug-resistant and extensively drug-resistant strains. DNA gyrase, specifically the ATPase domain of GyrB, represents a promising target for the development of…

  8. Artikel Jurnal

    Genomic characterization of drug-resistant Mycobacterium tuberculosis complex in western Kenya reveals predominance of isoniazid resistance and discordance with routine susceptibility testing

    Susan Musau; Susan Odera; Victor Moses Musyoki dkk.

    Frontiers in Tuberculosis, Vol. 4 · 2026 · Inggris · DOAJ

    IntroductionWhole-genome sequencing (WGS) data on resistance patterns in western Kenya remain limited. We evaluated resistant patterns of Mycobacterium tuberculosis complex (MTBC) isolates from western Kenya based on routine line probe assay (LPA) and/or phenotypic drug-susceptibility testing (DST)…

  9. Artikel Jurnal

    Differential roles of resident lung macrophages during control of murine alveolar and airway Mycobacterium abscessus infection

    Kelsey C. Haist; Jack H. Congel; Jodi M. Corley dkk.

    Frontiers in Tuberculosis, Vol. 4 · 2026 · Inggris · DOAJ

    IntroductionMycobacterium abscessus (Mabsc), a nontuberculous mycobacterium (NTM), is readily cleared from healthy lungs but can cause infections in immunocompromised individuals and individuals with chronic airways diseases that disrupt mucociliary clearance, such as cystic fibrosis and…

  10. Artikel Jurnal

    Non-tuberculous mycobacteria pulmonary disease in Texas: an analysis of 8 years of hospital discharge data

    Alex Baham; Jotam G. Pasipanodya; Devanshi Mehta dkk.

    Frontiers in Tuberculosis, Vol. 4 · 2026 · Inggris · DOAJ

    BackgroundNon-tuberculous mycobacterial (NTM) pulmonary disease (PD) is a recognized chronic condition associated with high healthcare utilization. Texas statewide NTM diagnosis-coded inpatient discharges per 100,000 discharge records (healthcare utilization) have not been systematically…

  11. Artikel Jurnal

    Sigma factor M induces an ESX-4-focused regulon in Mycobacterium abscessus

    Jill G. Canestrari; Shawn Gianola; Keith M. Derbyshire dkk.

    Frontiers in Tuberculosis, Vol. 4 · 2026 · Inggris · DOAJ

    Mycobacteria encode as many as five distinct Type VII (ESX) secretion systems that function in nutrient acquisition, cell-cell interaction, membrane integrity and pathogenesis. The biological activities of ESX systems are determined by the effector proteins they secrete. ESX-4 is the ancestral…

  12. Artikel Jurnal

    Adjunctive antimycobacterial and immunomodulatory effects of Allium cepa (pink variety) in a rabbit model of latent-like mycobacterial infection

    Theophilus Kwesi Ninkyi; Eric Ogyam; Kelvin Atta Agyapong dkk.

    Frontiers in Tuberculosis, Vol. 4 · 2026 · Inggris · DOAJ

    IntroductionLatent tuberculosis infection (LTBI) represents a major global reservoir for active disease, characterized by persistent, metabolically inactive bacilli that are difficult to eradicate. Novel therapeutic approaches targeting bacterial persistence and host immune responses are…

  13. Artikel Jurnal

    Implementation of sequencing-based surveillance for drug-resistant tuberculosis in Nigeria

    Heather P. McLaughlin; Israel Audu; Monday Tola dkk.

    Frontiers in Tuberculosis, Vol. 4 · 2026 · Inggris · DOAJ

    Sequencing for drug-resistant tuberculosis (DR-TB) surveillance was established in Nigeria for the first time, demonstrating a nationally coordinated referral network for multi-disease sequencing services. Mycobacterium tuberculosis isolates previously identified as resistant to rifampicin and/or…

  14. Artikel Jurnal

    The AcasR-FadD9 regulatory axis modulates iron homeostasis and susceptibility to the anti-mycobacterial compound ACA

    Feng Huang; Zixin Wang; Dong Jiang dkk.

    Frontiers in Tuberculosis, Vol. 4 · 2026 · Inggris · DOAJ

    Mycobacterial drug resistance leads to prolonged treatment, increased mortality, and increased healthcare costs. In this study, 3-azidothiophene-2-carboxylic acid (ACA), a dual-targeting inhibitor of the cell assembly proteins CpsA1 and CpsA2, exerted its activity through an iron-dependent pathway…

  15. Artikel Jurnal

    A Mycobacterium tuberculosis rare variable antigen vaccine reduces lung pathology in hypersusceptible SP140−/− mice

    Zachary P. Howard; Alexander Mohapatra; Weihao Zheng dkk.

    Frontiers in Tuberculosis, Vol. 4 · 2026 · Inggris · DOAJ

    Mycobacterium tuberculosis is the leading cause of death globally due to a single infectious agent. Currently, no licensed vaccine protects against pulmonary tuberculosis, the primary adult disease caused by Mtb infection. CD4 T cells are essential in protection against Mtb infection and inducing a…

  16. Artikel Jurnal

    Secreted proteins of Mycobacterium tuberculosis as therapeutic targets for drug discovery

    Anthony Musaazi Kaweesa; Divya Tiwari

    Frontiers in Tuberculosis, Vol. 4 · 2026 · Inggris · DOAJ

    Mycobacterium tuberculosis (M. tuberculosis), the causative agent of tuberculosis secretes proteins during the host-pathogen interaction that facilitate its survival and/or virulence within host cells. Key examples include EsxA and EsxB, CpnT/TNT, phosphatases (SapM, PtpA, PtpB), protein kinase G…

  17. Artikel Jurnal

    Evaluation of the performance of promising host transcriptional biosignatures in predicting TB progression during a 1-year prospective cohort study in Indian household contacts

    Synne Jenum; Steffen Hadasch; Dhanasekaran Sivakumaran dkk.

    Frontiers in Tuberculosis, Vol. 4 · 2026 · Inggris · DOAJ

    IntroductionAchieving the goal of the End TB Strategy depends on new tools, preferably blood-based point-of-care (POC) tests, to identify individuals at risk of progression from M. tuberculosis infection to subclinical or clinical tuberculosis (TB). A decade of signature discovery and validation…

  18. Artikel Jurnal

    Dose optimization of inhaled tigecycline in humans to overcome inherent adverse events and maximize bacterial clearance using a physiologically-based pharmacokinetic modeling approach

    Hyunseo Park; Amarinder Singh; Ashish Srivastava dkk.

    Frontiers in Tuberculosis, Vol. 4 · 2026 · Inggris · DOAJ

    IntroductionIntrapulmonary delivery of tigecycline has been highlighted as an optimal strategy for enhancing local drug concentrations at the site of infection in the treatment of Mycobacterium abscessus pulmonary infections. Therefore, determining an appropriate inhaled dose is imperative to…

  19. Artikel Jurnal

    Advanced diagnostic methods for nontuberculous mycobacterial infections

    Sneha Singh; Amresh Kumar Singh; Sushil Kumar dkk.

    Frontiers in Tuberculosis, Vol. 4 · 2026 · Inggris · DOAJ

    Nontuberculous mycobacteria (NTM) represent an increasingly significant cause of pulmonary and extrapulmonary infections, but are sometimes misinterpreted as tuberculosis (TB) owing to overlapping clinical and microbiological characteristics. Conventional diagnostic approaches, such as…